Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nicholas G. O'Connor"'
Autor:
Runa Kuley, Bhargavi Duvvuri, Jeffrey J. Wallin, Nam Bui, Mary Vic Adona, Nicholas G. O’Connor, Sharon K. Sahi, Ian B. Stanaway, Mark M. Wurfel, Eric D. Morrell, W. Conrad Liles, Pavan K. Bhatraju, Christian Lood
Publikováno v:
Virulence, Vol 14, Iss 1 (2023)
ABSTRACTNeutrophil dysregulation is well established in COVID-19. However, factors contributing to neutrophil activation in COVID-19 are not clear. We assessed if N-formyl methionine (fMet) contributes to neutrophil activation in COVID-19. Elevated l
Externí odkaz:
https://doaj.org/article/68bb341cfe6c496ea2f3d2dd7b86a2b7
Autor:
Neha A. Sathe, MD, MSc, Ana Mostaghim, MD, Elizabeth Barnes, BS, Nicholas G. O’Connor, BS, Sharon K. Sahi, MS, Sana S. Sakr, PhD, Jana M. Zahlan, BS, Craig H. Smith, MD, Michael Fitzpatrick, BS, Eric D. Morrell, MD, W. Conrad Liles, MD, PhD, Pavan K. Bhatraju, MD, MSc
Publikováno v:
Critical Care Explorations, Vol 5, Iss 7, p e0945 (2023)
IMPORTANCE:. Kidney and lung injury are closely inter-related during acute respiratory illness, but the molecular risk factors that these organ injuries share are not well defined. OBJECTIVES:. We identified plasma biomarkers associated with severe a
Externí odkaz:
https://doaj.org/article/4aa7528dc2fe41138a4f33b228f41845
Autor:
F. Linzee Mabrey, MD, Pavan K. Bhatraju, MD, MSc, Eric D. Morrell, MD, Leila R. Zelnick, PhD, Neha A. Sathe, MD, Nicholas G. O’Connor, BS, Carmen Mikacenic, MD, Thomas R. Martin, MD, W. Conrad Liles, MD, PhD, Mark M. Wurfel, MD, PhD
Publikováno v:
Critical Care Explorations, Vol 4, Iss 12, p e0813 (2022)
OBJECTIVES:. To identify and characterize clinical decline after completion of dexamethasone in severe COVID-19 and determine whether interleukin (IL)-6 and other inflammatory biomarkers predict the occurrence of clinical decline. DESIGN:. Prospectiv
Externí odkaz:
https://doaj.org/article/702f096281464ae990290eca015e72e5
Autor:
F. Linzee Mabrey, MD, Leila R. Zelnick, PhD, Eric D. Morrell, MD, Nicholas G. O’Connor, BS, Andrew Hart, BA, Mark M. Wurfel, MD, PhD, W. Conrad Liles, MD, PhD, Pavan K. Bhatraju, MD, MSc
Publikováno v:
Critical Care Explorations, Vol 4, Iss 9, p e0754 (2022)
OBJECTIVES:. To determine whether the early serologic response in COVID-19 critical illness is associated with hospital mortality. To evaluate if time-to-seroconversion differs by receipt of dexamethasone therapy. DESIGN:. Patients were prospectively
Externí odkaz:
https://doaj.org/article/045d78be8b9646edaf410f124a463afc